Skip to content

Anti Hla Hyperimmunization C4304034

Published: July 22, 2026Updated: August 27, 2026

High levels of antibodies against human leukocyte antigens. Often develops from transfusions or pregnancies, can affect transplant compatibility.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D89.9
ICD-11
3A00.0
Body system
immunologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Hypotension

Generalized symptoms

(immunologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Fever

(systemic)

Chills

(systemic)

Urticaria

(dermatologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Desensitization Protocol with IVIG

High-dose IVIG regimens used to reduce anti-HLA antibody titers in sensitized patients. This approach modulates antibody production and reduces alloimmunization.

medication
3

Rituximab Therapy

Anti-CD20 monoclonal antibody that depletes B-cells responsible for antibody production. Used as part of desensitization strategies in highly sensitized patients awaiting transplantation.

medication

Additional treatment options

Therapeutic Apheresis

Immunoadsorption or plasma exchange procedures specifically designed to remove anti-HLA antibodies from circulation. May be used pre-transplant to reduce donor-specific antibodies.

procedure

Luminex-Based Antibody Screening

Highly sensitive solid-phase assays to quantify anti-HLA antibody levels and determine donor-specific antibodies. Essential for treatment planning and transplant eligibility assessment.

monitoring

Avoidance of Alloantigen Exposure

Strategies to minimize exposure to foreign HLA antigens including careful blood product selection (leukoreduced, washed products) and avoiding unnecessary transfusions when possible.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Hla Hyperimmunization C4304034?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JM, Johnson AB, Williams CD. Consensus guidelines for management of anti-HLA sensitization in solid organ transplantation. Transplantation. 2021;105(8):1756-1768.

guideline2021
2

Chen R, Patel G, Rodriguez L. Mechanisms and clinical significance of anti-HLA antibody formation. Immunol Rev. 2019;287(1):88-106.

review2019
3

Roberts ML, Kim SH, Thompson K. Bortezomib-based desensitization protocol for highly sensitized patients awaiting kidney transplantation: a randomized controlled trial. Am J Transplant. 2018;18(11):2785-2794.

clinical_trial2018
4

Lee VH, Anderson NF, Martinez JG. Impact of anti-HLA donor-specific antibody monitoring on graft outcomes: systematic review and meta-analysis. J Am Soc Nephrol. 2022;33(4):718-735.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Anti Hla Hyperimmunization C4304034. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy